Form 4 for CRL Charles River Laboratories
Accepted 2023-08-14 00:00:00 ET · period of report 2023-08-10 · accession 0001127602-23-022480 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-14 | 2023-08-10 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $216.52 | -700 | 25.0K | -3% | -$151.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-10 | S | D | 700 | $216.52 | 24,983 | D | — | — |